These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

312 related items for PubMed ID: 18940118

  • 1. Post-transplant outcome in chronic myeloid leukaemia.
    Raza S, Ullah K, Ahmed P, Khan B, Kamal MK.
    J Coll Physicians Surg Pak; 2008 Oct; 18(10):615-9. PubMed ID: 18940118
    [Abstract] [Full Text] [Related]

  • 2. [Effects and prognostic factors of HLA-matched sibling donor allogeneic hematopoietic stem cell transplantation for chronic myelogenous leukemia].
    Tong XZ, Li J, Tan EX, Zhang GC, Wu XY, Peng AH, Zheng D, Zou WY, Hong WD, Luo SK.
    Zhonghua Zhong Liu Za Zhi; 2006 Jul; 28(7):545-8. PubMed ID: 17147125
    [Abstract] [Full Text] [Related]

  • 3. [Hematopoietic stem cell transplantation for patients with chronic myelogenous leukemia].
    Liu QF, Sun J, Zhang Y, Liu XL, Xu D, Xu B, Feng R, Meng FY, Zhou SY.
    Ai Zheng; 2004 Apr; 23(4):426-9. PubMed ID: 15087032
    [Abstract] [Full Text] [Related]

  • 4. Post-transplant infections: single center experience from the developing world.
    Ullah K, Raza S, Ahmed P, Chaudhry QU, Satti TM, Ahmed S, Mirza SH, Akhtar F, Kamal K, Akhtar FM.
    Int J Infect Dis; 2008 Mar; 12(2):203-14. PubMed ID: 17920999
    [Abstract] [Full Text] [Related]

  • 5. Unrelated donor bone marrow transplantation as treatment for chronic myeloid leukemia: the Spanish experience. The Chronic Myeloid Leukemia Subcommittee of the GETH. Grupo Español de Trasplante Hemopoyético.
    Carreras E, Tomás JF, Sanz G, Iriondo A, Boqué C, López J, Cabrera R, Sureda A, de Soria VG, Sierra J, Sanz MA, Torres A.
    Haematologica; 2000 May; 85(5):530-8. PubMed ID: 10800172
    [Abstract] [Full Text] [Related]

  • 6. Validation of the EBMT risk score in chronic myeloid leukemia in Brazil and allogeneic transplant outcome.
    De Souza CA, Vigorito AC, Ruiz MA, Nucci M, Dulley FL, Funcke V, Tabak D, Azevedo AM, Byington R, Macedo MC, Saboya R, Penteado Aranha FJ, Oliveira GB, Zulli R, Martins Miranda EC, Azevedo WM, Lodi FM, Voltarelli JC, Simões BP, Colturato V, De Souza MP, Silla L, Bittencourt H, Piron-Ruiz L, Maiolino A, Gratwohl A, Pasquini R.
    Haematologica; 2005 Feb; 90(2):232-7. PubMed ID: 15710577
    [Abstract] [Full Text] [Related]

  • 7. Allogeneic blood stem cell transplantation in chronic myeloid leukaemia-chronic phase following conditioning with busulphan and cyclophosphamide: a follow up report.
    Saikia TK, Parikh PM, Tawde S, Amare-Kadam PS, Rajadhyaksha S, Chhaya S.
    Natl Med J India; 2004 Feb; 17(2):71-3. PubMed ID: 15141598
    [Abstract] [Full Text] [Related]

  • 8. HLA-mismatched/haploidentical hematopoietic stem cell transplantation without in vitro T cell depletion for chronic myeloid leukemia: improved outcomes in patients in accelerated phase and blast crisis phase.
    Xiao-Jun H, Lan-Ping X, Kai-Yan L, Dai-Hong L, Huan C, Wei H, Yu-Hong C, Jing-Zhi W, Yao C, Xiao-Hui Z, Hong-Xia S, Dao-Pei L.
    Ann Med; 2008 Feb; 40(6):444-55. PubMed ID: 18608121
    [Abstract] [Full Text] [Related]

  • 9. [Allogeneic hematopoietic stem cell transplantation in patients with chronic myeloid leukemia in the Czech Republic--a retrospective analysis of results in years 1988-2005].
    Faber E, Koza V, Vítek A, Mayer J, Sedlácek P, Zák P, Zapletalová J, Benesová K, Krejcová H, Steinerová K, Maresová I, Cetkovský P.
    Vnitr Lek; 2006 Dec; 52(12):1172-80. PubMed ID: 17299910
    [Abstract] [Full Text] [Related]

  • 10. Bone marrow transplant cure for beta-thalassaemia major: initial experience from a developing country.
    Ullah K, Khan B, Raza S, Ahmed P, Satti TM, Butt T, Tariq WZ, Kamal MK.
    Ann Hematol; 2008 Aug; 87(8):655-61. PubMed ID: 18458905
    [Abstract] [Full Text] [Related]

  • 11. Results of allogeneic bone marrow transplant in chronic myeloid leukaemia following conditioning with busulfan and cyclophosphamide.
    Saikia TK, Advani SH, Parikh PM, Bapna A, Somjee S, Mukhopadhyay A, Gopal R, Nair CN.
    J Assoc Physicians India; 1999 Aug; 47(8):770-3. PubMed ID: 10778619
    [Abstract] [Full Text] [Related]

  • 12. [HLA-identical sibling allogeneic hematopoietic stem cell transplantation for chronic myelogenous leukemia in first chronic phase. Analysis of 51 cases].
    He Y, Feng SZ, Wang M, Wei JL, Qin TJ, Zhou Z, Zhai WJ, Qiu LG, Han MZ.
    Zhonghua Xue Ye Xue Za Zhi; 2005 Jul; 26(7):389-92. PubMed ID: 16251016
    [Abstract] [Full Text] [Related]

  • 13. Allogeneic stem cell transplantation in chronic myeloid leukaemia--2 1/2 year experience.
    Hashmi K, Khan B, Ahmed P, Hussain I, Raza S, Iqbal H, Malik HS, Kamal MK, Anwar M.
    J Pak Med Assoc; 2005 Nov; 55(11):478-82. PubMed ID: 16304866
    [Abstract] [Full Text] [Related]

  • 14. Equivalent survival for sibling and unrelated donor allogeneic stem cell transplantation for acute myelogenous leukemia.
    Moore J, Nivison-Smith I, Goh K, Ma D, Bradstock K, Szer J, Durrant S, Schwarer A, Bardy P, Herrmann R, Dodds A.
    Biol Blood Marrow Transplant; 2007 May; 13(5):601-7. PubMed ID: 17448920
    [Abstract] [Full Text] [Related]

  • 15. Influence of CD34(+) marrow cell dose on outcome of HLA-identical sibling allogeneic bone marrow transplants in patients with chronic myeloid leukaemia.
    Morariu-Zamfir R, Rocha V, Devergie A, Socié G, Ribaud P, Esperou H, Parquet N, Guardiola P, Dal Cortivo L, Bittencourt H, Garnier F, Traineau R, Marolleau JP, Chevret S, Gluckman E.
    Bone Marrow Transplant; 2001 Mar; 27(6):575-80. PubMed ID: 11319585
    [Abstract] [Full Text] [Related]

  • 16. Comparison of anthracycline-based combination chemotherapy with or without all-trans retinoic acid in acute promyelocytic leukemia.
    Raza S, Ullah K, Ahmed P, Khan B.
    J Coll Physicians Surg Pak; 2008 Sep; 18(9):546-50. PubMed ID: 18803891
    [Abstract] [Full Text] [Related]

  • 17. Reduced-intensity conditioning for allogeneic stem cell transplantation in patients with chronic myeloid leukemia is associated with better overall survival but inferior disease-free survival when compared with myeloablative conditioning - a retrospective study of the Czech National Hematopoietic Stem Cell Transplantation Registry.
    Faber E, Koza V, Vitek A, Mayer J, Sedlacek P, Zak P, Zapletalova J, Benesova K, Krejcova H, Steinerova K, Maresova I, Cetkovsky P, Czech National Hematopoietic Stem Cell Transplantation Registry.
    Neoplasma; 2007 Sep; 54(5):443-6. PubMed ID: 17688375
    [Abstract] [Full Text] [Related]

  • 18. Clinical impact of graft-versus-host disease against leukemias not in remission at the time of allogeneic hematopoietic stem cell transplantation from related donors. The Japan Society for Hematopoietic Cell Transplantation Working Party.
    Kataoka I, Kami M, Takahashi S, Kodera Y, Miyawaki S, Hirabayashi N, Okamoto S, Matsumoto N, Miyazaki Y, Morishita Y, Asai O, Maruta A, Yoshida T, Imamura M, Hamajima N, Matsuo K, Harada M, Mineishi S, Japan Society for Hematopoietic Cell Transplantation Working Party.
    Bone Marrow Transplant; 2004 Oct; 34(8):711-9. PubMed ID: 15361916
    [Abstract] [Full Text] [Related]

  • 19. Allogeneic haematopoietic cell transplantation for chronic myelogenous leukaemia in the era of imatinib: a retrospective multicentre study.
    Bornhäuser M, Kröger N, Schwerdtfeger R, Schafer-Eckart K, Sayer HG, Scheid C, Stelljes M, Kienast J, Mundhenk P, Fruehauf S, Kiehl MG, Wandt H, Theuser C, Ehninger G, Zander AR, Cooperative German Transplant Study Group.
    Eur J Haematol; 2006 Jan; 76(1):9-17. PubMed ID: 16343266
    [Abstract] [Full Text] [Related]

  • 20. A low body mass index is correlated with poor survival after allogeneic stem cell transplantation.
    Le Blanc K, Ringdén O, Remberger M.
    Haematologica; 2003 Sep; 88(9):1044-52. PubMed ID: 12969813
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.